| +0.51 / +0.27%|
The 19 analysts offering 12-month price forecasts for Allergan Inc have a median target of 204.00, with a high estimate of 230.00 and a low estimate of 174.00. The median estimate represents a +7.40% increase from the last price of 189.95.
The current consensus among 23 polled investment analysts is to Buy stock in Allergan Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.